Long-term maintenance requires continued medication in most cases
The Shot is stronger: If your goal is maximum weight loss, the data shows that Injectable Wegovy and Zepbound still work better for the average person
Food intake declines and hunger is reduced
Global NASH Council, American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, European Liver Patients' Association - ELPA, Global Liver Institute, Priti Chawla, Obesity Matters, American Diabetes Association Fatty Liver Alliances Post GLP-1 receptor agonists (GLP-1RAs) show promise in managing metabolic dysfunction-associated steatotic liver disease (MASLD) by reducing hepatic steatosis, resolving MASH, and mitigating fibrosis progression
Patients often report improvements in conditions associated with excess body fat, such as lower cholesterol, blood pressure, and blood sugar levels
Here are some smart questions to keep in mind: Is GLP-1 right for my goals